Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Active immunization to luteinizing hormone releasing hormone to inhibit the induction of mammary tumors in the rat

Journal Article · · Life Sci.; (United States)
Immunization of female rats with a bovine serum albumin-luteinizing hormone releasing hormone conjugate results in suppression of dimethylbenzanthracene mammary tumor incidence. Tumor incidence was 1.3, and 1.29 tumors per rat in bovine serum albumin alone (n = 10) and unimmunized (n = 18) control groups, but no tumors were found in the bovine serum albumin-luteinizing hormone releasing hormone conjugate immunized animals (n = 10). In a second experiment immunization with bovine serum albumin-luteinizing hormone releasing hormone conjugates reduced tumor incidence to 0.3 tumors per rat (n = 10) from the 1.2 tumors per animal seen in the control animals (n = 10) immunized with bovine serum albumin alone. Bovine serum albumin-luteinizing hormone immunization caused the production of anti-LHRH antibodies, an interruption of estrous cycles, lowered serum estradiol and progesterone levels, and atrophy of the ovaries and uteri. Immunization BSA-hormone conjugates is a novel anti-tumor strategy.
Research Organization:
Univ. of Wisconsin Cancer Center, Madison (USA)
OSTI ID:
7189139
Journal Information:
Life Sci.; (United States), Journal Name: Life Sci.; (United States) Vol. 43:2; ISSN LIFSA
Country of Publication:
United States
Language:
English